TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 95 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $590,000 | +8.7% | 8,871 | 0.0% | 0.05% | -48.0% |
| Q1 2020 | $543,000 | -50.8% | 8,871 | -29.3% | 0.10% | -33.8% |
| Q4 2019 | $1,104,000 | +65.0% | 12,552 | +41.6% | 0.15% | +13.5% |
| Q3 2019 | $669,000 | +190.9% | 8,865 | +228.8% | 0.13% | +375.0% |
| Q2 2019 | $230,000 | -21.0% | 2,696 | 0.0% | 0.03% | -33.3% |
| Q1 2019 | $291,000 | – | 2,696 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |